Back to results list
Show full item record
WEB OF SCIENCETM
Please use this identifier to cite or link to this item:
|Title:||Lycium barbarum polysaccharides in ageing and its potential use for prevention and treatment of osteoarthritis : a systematic review||Authors:||Ni, J
|Issue Date:||2021||Source:||BMC Complementary medicine and therapies, 2021, v. 21, no. 1, 212||Abstract:||Background: Lycium barbarum polysaccharide (LBP), the most abundant functional component of wolfberry, is considered a potent antioxidant and an anti-ageing substance. This review aims to outline the hallmarks of ageing in the pathogenesis of osteoarthritis (OA), followed by the current understanding of the senolytic effect of LBP and its potential use in the prevention and treatment of OA. This will be discussed through the lens of molecular biology and herbal medicine.
Methods: A literature search was performed from inception to March 2020 using following keywords: “Lycium barbarum polysaccharide”, “DNA damage”, antioxidant, anti-apoptosis, anti-inflammation, anti-ageing, osteoarthritis, chondrocytes, fibroblasts, osteoblasts, osteoclasts, and “bone mesenchymal stem cell”. The initial search yielded 2287 papers, from which 35 studies were selected for final analysis after screening for topic relevancy by the authors.
Results: In literature different in vitro and in vivo ageing models are used to demonstrate LBP’s ability to reduce oxidative stress, restore mitochondrial function, mitigate DNA damage, and prevent cellular senescence. All the evidence hints that LBP theoretically attenuates senescent cell accumulation and suppresses the senescence-associated secretory phenotype as observed by the reduction in pro-inflammatory cytokines, like interleukin-1beta, and matrix-degrading enzymes, such as MMP-1 and MMP-13. However, there remains a lack of evidence on the disease-modifying effect of LBP in OA, although its chondroprotective, osteoprotective and anti-inflammatory effects were reported.
Conclusion: Our findings strongly support further investigations into the senolytic effect of LBP in the context of age-related OA.
Lycium Barbarum polysaccharides
Reactive oxidative species
|Publisher:||BioMed Central Ltd.||Journal:||BMC Complementary medicine and therapies||EISSN:||2662-7671||DOI:||10.1186/s12906-021-03385-0||Rights:||© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you giveappropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate ifchanges were made. The images or other third party material in this article are included in the article's Creative Commonslicence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commonslicence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtainpermission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to thedata made available in this article, unless otherwise stated in a credit line to the data.
The following publication Ni, J., Au, M., Kong, H. et al. Lycium barbarum polysaccharides in ageing and its potential use for prevention and treatment of osteoarthritis: a systematic review. BMC Complement Med Ther 21, 212 (2021) is available at https://doi.org/10.1186/s12906-021-03385-0
|Appears in Collections:||Journal/Magazine Article|
Show full item record
Citations as of May 22, 2022
Citations as of May 27, 2022
WEB OF SCIENCETM
Citations as of May 26, 2022
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.